Latest genomic medicine News

AstraZeneca announces collaboration and investment agreement with Cellectis to accelerate cell therapy and genomic medicine ambitions
Groundbreaking gene therapy trial for Hunter syndrome opens
Alexion completes purchase and licence agreement for early-stage rare disease gene therapy portfolio from Pfizer
Lifesaving bedside stroke test receives UK product safety mark
Severe Covid can alter long-term immune response
Alexion, AstraZeneca Rare Disease, enters agreement with Pfizer to acquire a portfolio of preclinical rare disease gene therapies
Genomic profiling offers hope for 23,000 cancer patients
Are we ready for gene testing and genetic medicine?
Stuttering gene. Cerebral palsy. Fast living killifish. Testing concerns
Precision medicine for Indigenous communities
Personalized Gut Microbiome Analysis for Colorectal Cancer Classification with Explainable AI
Greater Manchester secures multi-million investment to improve the diagnosis and treatment of disease to save more lives
Orkney cancer gene link revealed
Early results of gene therapy trial for ‘childhood dementia’ show promise
Genetic test to prevent newborn babies going deaf recommended by NICE
World-first genetic test for babies’ hearing wins major award
Genomics key to First Nations health equality
Rogue immune cells linked to leukaemia are key driver of a
Tumour matrix profiling gives clues to progression of some l
Renowned Dunedin Study wins Rutherford Medal
Illumina unveils NovaSeq X series to accelerate genomic discoveries
Transcript: Misha Schubert on Startup Daily 7 Sept 2022
Breakthrough For Kidney Disease Patients
Leading scientists use Genomics England data set to propose updated global guidelines to improve rare disease diagnosis